Flagright, a new AI operating system for compliance, just secured $12.5M in funding.
The Story
Its founder spent 15 months searching for financial crime software that did not exist.
Why It Matters
Compliance is not optional in pharma, and the Flagright story highlights a clear market need for AI-driven regulatory tools. As the EU AI Act enforcement approaches, CROs and small biotech must consider AI for automating complex regulatory reporting and data integrity checks. This could shift resources from manual review to scientific innovation. However, governed execution is key here.
What To Do About It
Don't wait for perfect software to appear. Start by auditing your current compliance workflows for manual, repetitive tasks suitable for AI automation. I can help map your existing regulatory processes against available tools, focusing on GDPR-compliant, local-first solutions.
